PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12425199-8	2002	On comparison of other risk factors in groups of patients with a BP below 130/85 mm Hg and higher than this borderlimit line it was revealed that one-year treatment of hypertension with trandolapril--4 mg alone or combined with verapamil 240 mg led to a greater reduction of the pulse rate, fasting insulin level, hematicrit and triglycerides and to an increase of HDL-cholesterol.	trandolapril	186-198	insulin	Homo sapiens	299-306	
12421112-8	2002	Trandolapril/verapamil SR had a neutral or beneficial effect on metabolic parameters (glucose, insulin, lipids) in patients with hypertension, including those with type 2 diabetes.	trandolapril	0-12	insulin	Homo sapiens	95-102	
11274903-10	2001	In conclusion, within 14 days of trandolapril treatment, circadian blood pressure variation was successfully restored in normoalbuminuric normotensive insulin-dependent diabetic patients.	trandolapril	33-45	insulin	Homo sapiens	151-158	
10694831-0	2000	Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.	trandolapril	110-122	insulin	Homo sapiens	13-20	
9752891-0	1998	Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril.	trandolapril	230-242	insulin	Homo sapiens	95-102	
7512473-6	1993	Preliminary results of an ongoing study investigating the effects of trandolapril or the diuretic combination of hydrochlorothiazide and triamterene on serum glucose and insulin levels are presented.	trandolapril	69-81	insulin	Homo sapiens	170-177	
10746484-0	2000	Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days" treatment with trandolapril.	trandolapril	97-109	insulin	Homo sapiens	0-7	
10746484-1	2000	AIMS: The aims of this study were to examine the effects of trandolapril, a long acting angiotensin converting enzyme (ACE) inhibitor with high tissue uptake, on insulin sensitivity and lipid concentrations in hypertensive patients with Type 2 diabetes mellitus.	trandolapril	60-72	insulin	Homo sapiens	162-169	
7519694-7	1994	Thus, the combination of Ca(2+)-channel blockade by sustained release verapamil and ACE inhibition by trandolapril in insulin-resistant type II diabetic patients with essential hypertension appears to be promising in terms of possible synergistic effects.	trandolapril	102-114	insulin	Homo sapiens	118-125